Sara Oubari - Publications

RNA-based full length immunoglobulin light chain sequencing reveals lambda constant domain mutations with potential implications for thermodynamic stability in light chain amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 04, 2026

Determinants of Long-Term Benefit From High Dose Melphalan With Autologous Stem Cell Transplant in AL Amyloidosis.

Journal: American journal of hematology

Published: March 17, 2026

Early timepoint 99mTc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosis.

Journal: EJNMMI research

Published: February 10, 2026

Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases.

Journal: HemaSphere

Published: January 20, 2026

Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival.

Journal: Annals of hematology

Published: January 17, 2025

Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival.

Journal: Haematologica

Published: April 10, 2023

Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.

Journal: Journal of neurology

Published: January 10, 2023

Prevalence and predictors of neurological manifestations in systemic AL amyloidosis.

Journal: Journal of the neurological sciences

Published: March 07, 2022

Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma.

Journal: Cancers

Published: February 25, 2022

Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosis.

Journal: Annals of clinical and translational neurology

Published: February 10, 2022

A novel TTR mutation (p.Ala65Val) underlying late-onset hereditary transthyretin (ATTRv) amyloidosis with mixed cardiac and neuropathic phenotype: a case report.

Journal: BMC neurology

Published: December 15, 2021

Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.

Journal: ESC heart failure

Published: September 16, 2021